Detection of neural autoantibodies with accurate laboratory assays in patients with compatible clinical-MRI phenotypes allows ...

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...

KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, ...